Seiya Momosaki
Overview
Explore the profile of Seiya Momosaki including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
66
Citations
471
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Matsuo S, Amano T, Miyamatsu Y, Hayashi D, Yamashita S, Momosaki S, et al.
Neurocirugia (Astur : Engl Ed)
. 2022 Nov;
33(6):345-349.
PMID: 36333091
Proliferative activity examined by Ki67 labeling index (LI) plays pivotal role for managing gastrointestinal neuroendocrine tumor (GI-NET). Few reports indicated the intra-patient heterogeneity of Ki67-LI among metastatic tumor sites. We...
2.
Adachi S, Yamashita K, Nakamizo A, Amano T, Momosaki S, Noguchi T
Neuroradiol J
. 2022 May;
35(6):777-779.
PMID: 35503008
We report a case of cystic meningioma at the left cerebellopontine angle (CPA). Magnetic resonance imaging demonstrated both solid and cystic components in the tumor. The cystic component appeared slightly...
3.
Matsuo S, Amano T, Miyamatsu Y, Hayashi D, Yamashita S, Momosaki S, et al.
Neurocirugia (Astur : Engl Ed)
. 2021 Jun;
PMID: 34154907
Proliferative activity examined by Ki67 labeling index (LI) plays pivotal role for managing gastrointestinal neuroendocrine tumor (GI-NET). Few reports indicated the intra-patient heterogeneity of Ki67-LI among metastatic tumor sites. We...
4.
Saito S, Toyokawa G, Momosaki S, Kozuma Y, Shoji F, Yamazaki K, et al.
Thorac Cancer
. 2021 Jun;
12(15):2217-2220.
PMID: 34151529
Immune checkpoint inhibitors with chemotherapy have been shown to exhibit remarkable efficacy for advanced non-small-cell lung carcinoma and are under investigation as an induction therapy. However, the significance of preoperative...
5.
Wang Z, Kimura S, Iwasaki H, Takase K, Oshiro Y, Gamachi A, et al.
Diagn Pathol
. 2021 Jun;
16(1):48.
PMID: 34088321
Background: Systemic Epstein-Barr virus T-cell lymphoma (sEBV TCL) occurs in childhood and young adults, and is exceptionally rare in older adults. Methods: We investigated clinicopathological features in 16 patients of...
6.
Kanavati F, Toyokawa G, Momosaki S, Takeoka H, Okamoto M, Yamazaki K, et al.
Sci Rep
. 2021 Apr;
11(1):8110.
PMID: 33854137
The differentiation between major histological types of lung cancer, such as adenocarcinoma (ADC), squamous cell carcinoma (SCC), and small-cell lung cancer (SCLC) is of crucial importance for determining optimum cancer...
7.
Kyono M, Okamoto M, Sakamoto S, Iwanaga T, Momosaki S, Takeoka H, et al.
Mod Rheumatol Case Rep
. 2020 Oct;
4(2):248-252.
PMID: 33086997
A 52-year-old woman was diagnosed as having anti-centromere antibody (ACA)-positive primary Sjögren syndrome (pSS). Eight years later, she visited our hospital because she had developed dyspnoea. She was diagnosed as...
8.
Ueda M, Shoji F, Kozuma Y, Toyokawa G, Yamazaki K, Momosaki S, et al.
Ann Thorac Cardiovasc Surg
. 2020 Oct;
28(3):232-235.
PMID: 33071244
We describe a rare case of newly discovered pulmonary metastases and surgical confirmation 12 years after initial surgery for a pheochromocytoma. A 61-year-old asymptomatic man was referred because of an...
9.
Kanavati F, Toyokawa G, Momosaki S, Rambeau M, Kozuma Y, Shoji F, et al.
Sci Rep
. 2020 Jun;
10(1):9297.
PMID: 32518413
Lung cancer is one of the major causes of cancer-related deaths in many countries around the world, and its histopathological diagnosis is crucial for deciding on optimum treatment strategies. Recently,...
10.
Ohmura H, Ito M, Uchino K, Okada C, Tanishima S, Yamada Y, et al.
FEBS Open Bio
. 2019 Nov;
10(1):147-157.
PMID: 31736281
Epstein-Barr virus (EBV)-associated gastric cancer (GC) is associated with a high degree of DNA methylation. However, the association between chemotherapy susceptibility and tumor DNA methylation in advanced diseases remains unclear....